Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
6
×
crispr
6
×
life sciences
national blog main
national top stories
new york blog main
6
×
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
deals
ipo
novartis
startups
abbvie
biogen
cancer immunotherapy
clinical trials
editas medicine
eli lilly
fda
What
bio
roundup
life
science
companies
millions
moves
new
patients
talk
acquisitions
announced
approval
bails
becker
benefiting
billions
biogen’s
biopharmaceutical
black
boston
brand
bridgebio
capital
car
ceo
collabs
coming
continue
convo
covid
daniel
deal
debut
develop
diagnostics
diamond
diamond’s
dollars
drug
Language
unset
Current search:
crispr
×
cancer
×
" new york blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More